Gestamp Automocin Financials

7GA Stock   2.62  0.05  1.95%   
We strongly advise to harness analysis of Gestamp Automocin fundamentals to see if markets are presently mispricing the company. We are able to break down and analyze data for fourteen available reported financial drivers for Gestamp Automocin, which can be compared to its competitors. The stock experiences a large bullish trend. Check odds of Gestamp Automocin to be traded at 2.88 in 90 days.
  
Understanding current and past Gestamp Automocin Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Gestamp Automocin's financial statements are interrelated, with each one affecting the others. For example, an increase in Gestamp Automocin's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Gestamp Automocin's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Gestamp Automocin SA. Check Gestamp Automocin's Beneish M Score to see the likelihood of Gestamp Automocin's management manipulating its earnings.
InstrumentGermany Stock View All
ExchangeStuttgart Exchange
ISINES0105223004
BenchmarkDow Jones Industrial

Gestamp Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Gestamp Automocin's current stock value. Our valuation model uses many indicators to compare Gestamp Automocin value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Gestamp Automocin competition to find correlations between indicators driving Gestamp Automocin's intrinsic value. More Info.
Gestamp Automocin SA is the top company in current valuation category among its peers. It is rated fifth in price to book category among its peers . The ratio of Current Valuation to Price To Book for Gestamp Automocin SA is about  3,844,161,259 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Gestamp Automocin's earnings, one of the primary drivers of an investment's value.

Gestamp Automocin Systematic Risk

Gestamp Automocin's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Gestamp Automocin volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Gestamp Automocin correlated with the market. If Beta is less than 0 Gestamp Automocin generally moves in the opposite direction as compared to the market. If Gestamp Automocin Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Gestamp Automocin is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Gestamp Automocin is generally in the same direction as the market. If Beta > 1 Gestamp Automocin moves generally in the same direction as, but more than the movement of the benchmark.

Gestamp Automocin November 28, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Gestamp Automocin help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Gestamp Automocin SA. We use our internally-developed statistical techniques to arrive at the intrinsic value of Gestamp Automocin SA based on widely used predictive technical indicators. In general, we focus on analyzing Gestamp Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Gestamp Automocin's daily price indicators and compare them against related drivers.

Additional Tools for Gestamp Stock Analysis

When running Gestamp Automocin's price analysis, check to measure Gestamp Automocin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gestamp Automocin is operating at the current time. Most of Gestamp Automocin's value examination focuses on studying past and present price action to predict the probability of Gestamp Automocin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gestamp Automocin's price. Additionally, you may evaluate how the addition of Gestamp Automocin to your portfolios can decrease your overall portfolio volatility.